Liebermann Erica, Van Devanter Nancy, Frías Gúzman Natalia, Hammer Marilyn J, Ompad Danielle
New York University Rory Meyers College of Nursing, 433 First Avenue, 6th floor, New York, NY, 10010, USA.
Instituto Nacional de Cáncer Rosa Emilia Sánchez Pérez de Tavares (INCART), Avenida Correa y Cidrón, 10103, Santo Domingo, Dominican Republic.
J Cancer Educ. 2021 Dec;36(6):1170-1185. doi: 10.1007/s13187-020-01746-w.
Creating effective programs for cervical cancer prevention is essential to avoid premature deaths from cervical cancer. The Dominican Republic has persistently high rates of cervical cancer, despite the availability of Pap smear screening. This study explored Dominican provider attitudes towards human papillomavirus (HPV) testing and current challenges to effective cervical cancer prevention. In this Consolidated Framework for Implementation Research (CFIR)-driven mixed methods study, we conducted in-depth interviews (N = 21) and surveys (N = 202) with Dominican providers in Santo Domingo and Monte Plata provinces regarding their perspectives on barriers to cervical cancer prevention and their knowledge and attitudes towards HPV testing as an alternative to Pap smear. Providers believed the main barrier to cervical cancer prevention was lack of cervical cancer awareness and resulting inadequate population screening coverage. Providers felt that Pap smear was widely available to women in the Dominican Republic and were unsure how a change to HPV testing for screening would address gaps in current cervical cancer screening programs. A subset of providers felt HPV testing offered important advantages for early detection of cervical cancer and were in favor of more widespread use. Cost of the HPV test and target age for screening with HPV testing were the main barriers to acceptability. Providers had limited knowledge of HPV testing as a screening test. The group was divided in terms of the potential impact of a change in screening test in addressing barriers to cervical cancer prevention in the Dominican Republic. Findings may inform interventions to disseminate global evidence-based recommendations for cervical cancer screening.
制定有效的宫颈癌预防计划对于避免宫颈癌导致的过早死亡至关重要。尽管多米尼加共和国已有巴氏涂片筛查,但该国宫颈癌发病率一直居高不下。本研究探讨了多米尼加医疗服务提供者对人乳头瘤病毒(HPV)检测的态度以及当前有效预防宫颈癌面临的挑战。在这项由实施研究综合框架(CFIR)驱动的混合方法研究中,我们对圣多明各和蒙特普拉塔省的多米尼加医疗服务提供者进行了深度访谈(N = 21)和调查(N = 202),了解他们对宫颈癌预防障碍的看法以及对HPV检测替代巴氏涂片的知识和态度。医疗服务提供者认为,宫颈癌预防的主要障碍是缺乏对宫颈癌的认识,导致人群筛查覆盖率不足。他们觉得多米尼加共和国的女性广泛可以获得巴氏涂片检查,并且不确定改用HPV检测进行筛查将如何弥补当前宫颈癌筛查计划中的差距。一部分医疗服务提供者认为HPV检测在早期发现宫颈癌方面具有重要优势,并赞成更广泛地使用。HPV检测的成本和HPV检测的目标筛查年龄是可接受性的主要障碍。医疗服务提供者对HPV检测作为一种筛查检测的了解有限。对于筛查检测的改变在解决多米尼加共和国宫颈癌预防障碍方面的潜在影响,该群体存在分歧。研究结果可能为传播基于全球证据的宫颈癌筛查建议的干预措施提供参考。